Filter Results:
(6,558)
Show Results For
- All HBS Web
(6,558)
- People (18)
- News (2,177)
- Research (3,617)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,793)
Show Results For
- All HBS Web
(6,558)
- People (18)
- News (2,177)
- Research (3,617)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,793)
- July 2016 (Revised July 2019)
- Teaching Plan
Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)
By: Nori Gerardo Lietz and Ricardo Andrade
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
- July – August 2000
- Article
Drug Industry Mergers Won't Necessarily Benefit R&D
Henderson, Rebecca M. "Drug Industry Mergers Won't Necessarily Benefit R&D." Research-Technology Management 43, no. 4 (July–August 2000): 10–11.
- 05 May 2016
- News
The Real Cost of Ignoring Mental Health in the Workplace
- 28 Nov 2016
- News
What’s good for employee health is good for the company
- November 2013
- Article
Learning from My Successes and from Others' Failures: Evidence from Minimally Invasive Cardiac Surgery
By: D. KC, B. Staats and F. Gino
Learning from past experience is central to an organization's adaptation and survival. A key dimension of prior experience is whether an outcome was successful or unsuccessful. While empirical studies have investigated the effects of success and failure in... View Details
Keywords: Healthcare; Health Care; Knowledge Work; Attribution Theory; Quality; Success; Medical Specialties; Health Care and Treatment; Failure; Learning; Health Industry
KC, D., B. Staats, and F. Gino. "Learning from My Successes and from Others' Failures: Evidence from Minimally Invasive Cardiac Surgery." Management Science 59, no. 11 (November 2013): 2435–2449.
- September 1991 (Revised November 1991)
- Case
Health Promotion Centers of New England
Herzlinger, Regina E. "Health Promotion Centers of New England." Harvard Business School Case 192-035, September 1991. (Revised November 1991.)
- 01 Jun 2009
- News
Doctor Innovation—Shaking up the Health System
- May 1992 (Revised May 1993)
- Teaching Note
Hyatt Hill Health Center, Teaching Note
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
government's role in U.S. healthcare? What do you think? To Read More: Robert H. Frank, "A Health Care Plan So Simple, Even Stephen Colbert Couldn't Simplify It," The New York Times, February 18, 2007, p.... View Details
- 2016
- Blog
Building A Culture of Health - John A. Quelch: The Marketing of Prevention
By: John A. Quelch
The US will devote 17.5% of GDP to health care this year, around $3 trillion. Yet only 3 percent of that will be spent on prevention, including both primary prevention (preventing illness in the first place) and secondary prevention (preventing sick people getting... View Details
Keywords: Healthcare; Healthcare Marketing; Prevention; Wellbeing; Health; Marketing; Health Industry; Health Industry; Health Industry; Europe; North and Central America
Quelch, John A. "The Marketing of Prevention." Building A Culture of Health - John A. Quelch (blog). May 12, 2016. http://johnquelch.org/the-marketing-of-prevention/.
- February–March 2000
- Article
Market-Driven Health Care: Winners and Losers
Herzlinger, Regina E. "Market-Driven Health Care: Winners and Losers." Special Supplementary Issue RT: The Journal for Respiratory Care Practitioners (February–March 2000).
- September – October 2000
- Article
Will Disruptive Innovations Cure Health Care?
By: Clayton M. Christensen, Richard M.J. Bohmer and John Kenagy
Christensen, Clayton M., Richard M.J. Bohmer, and John Kenagy. "Will Disruptive Innovations Cure Health Care?" Harvard Business Review 78, no. 5 (September–October 2000): 102–117.
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care View Details
- September 2013
- Article
Converging to the Lowest Common Denominator in Physical Health
By: Leslie K. John and Michael I. Norton
Objective: This research examines how access to information on peer health behaviors affects one's own health behavior. Methods: We report the results of a randomized field experiment in a large corporation in which we introduced walkstations (treadmills... View Details
John, Leslie K., and Michael I. Norton. "Converging to the Lowest Common Denominator in Physical Health." Special Issue on Health Psychology Meets Behavioral Economics. Health Psychology 32, no. 9 (September 2013): 1023–1028.
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
Keywords: Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Africa; Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- October–December 2005
- Article
Medicine's Service Challenge: Blending Custom and Standard Care
By: Richard Bohmer
Bohmer, Richard. "Medicine's Service Challenge: Blending Custom and Standard Care." Health Care Management Review 30, no. 4 (October–December 2005): 322–330.
- June 2002 (Revised November 2005)
- Case
Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa
By: Debora L. Spar
In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details
Keywords: Patents; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
Spar, Debora L., and Nick Bartlett. "Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa." Harvard Business School Case 702-049, June 2002. (Revised November 2005.)
- May 2016
- Case
AbbVie
By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details